Regeneron Pharmaceuticals, Inc. Total Liabilities for the year ending December 31, 2024: USD 8.41 B

Regeneron Pharmaceuticals, Inc. Total Liabilities is USD 8.41 B for the year ending December 31, 2024, a 18.27% change year over year. Total liabilities are the total amount of a company's debts and other obligations.
  • Regeneron Pharmaceuticals, Inc. Total Liabilities for the year ending December 31, 2023 was USD 7.11 B, a 8.50% change year over year.
  • Regeneron Pharmaceuticals, Inc. Total Liabilities for the year ending December 31, 2022 was USD 6.55 B, a -1.73% change year over year.
  • Regeneron Pharmaceuticals, Inc. Total Liabilities for the year ending December 31, 2021 was USD 6.67 B, a 8.60% change year over year.
  • Regeneron Pharmaceuticals, Inc. Total Liabilities for the year ending December 31, 2020 was USD 6.14 B, a 65.20% change year over year.
Key Data
Date Total Liabilities Shareholders' Equity Cash and Short-Term Investments Receivables